BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220513T100000
DTEND;TZID=Europe/Madrid:20220513T120000
DTSTAMP:20260427T084332
CREATED:20220503T130848Z
LAST-MODIFIED:20220503T130848Z
UID:91647-1652436000-1652443200@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Iris Batalha
DESCRIPTION:Nanotherapeutics – ‘How we sometimes underestimate the influence of little things’\nIris L. Batalha\, Institute for Bioengineering of Catalonia (IBEC) \nDeaths caused by infections from antibiotic-resistant bacteria are expected to skyrocket over the next decades\, with a staggering 10 million deaths per year projected for 2050. Treating infections by intracellular pathogens\, such as M. tuberculosis\, is ‘a perfect storm’. The WHO revealed that while some 50 new antibiotics and 10 biologics are under development\, only half of those target WHO-priority pathogens and the majority have very limited benefits when compared to existing antibiotics. Reformulating existent drugs in nanocarriers may help achieving enhanced efficacy and safety while reducing dose frequency\, by providing temporal and localised control of drug exposure. In this talk\, I will present my work on the synthesis of dual-drug tunable nanoparticle-based antibiotics\, which showed increased bacterial killing efficacy in a zebrafish larval model of mycobacterial infection when compared to free drugs at the same concentration. In addition\, nanoparticles were able to efficiently penetrate mycobacterial cords and granulomatous lesions – shielded regions of difficult access by free drugs\, improving the therapeutic effect. \n\nIris Batalha is currently a Junior Leader Research Fellow at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona\, a Panel Tutor in Nanotherapeutics at the University of Cambridge Institute of Continuing Education\, a freelance Senior Innovation Consultant at Inspiralia (Spain and USA)\, a Co-founder\, Director and Editor-in-Chief of the non-profit organisation Women Ahead of Their Time (WATT)\, and a Research Associate at Peterhouse College. From 2017 to 2020\, she was a joint Research Associate at the Department of Engineering Nanoscience Centre and Department of Medicine Molecular Immunity Unit\, University of Cambridge. From 2014 to 2017\, she worked at the Department of Chemical Engineering and Biotechnology\, University of Cambridge\, and the biopharmaceutical company MedImmune/Astrazeneca\, followed by a brief experience as a healthcare/pharmaceutical consultant. Her research interests and expertise lie in medical and pharmaceutical research and development\, particularly in the fields of nanobiotechnology\, bio-inspired materials\, downstream processing\, formulation and drug delivery. \n  \nSala Baobab\, Tower I\, 11 Floor\, IBEC
URL:https://ibecbarcelona.eu/event/phd-discussions-iris-batalha/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
END:VCALENDAR